Concert Pharma Shares Fall 17%; Company Plans Public Offering of Stock
marketwatch.com
news
2022-05-31 20:25:00

By Stephen Nakrosis Shares of Concert Pharmaceuticals Inc. have fallen in Tuesday's after-hours market, following the company's announcement that it plans to sell 10 million shares of common stock in an underwritten registered public offering. All shares in the offering are to be sold by Concert, the company said. At 4:20 p.m. ET, the company's stock had fallen 17.45% to trade at $5.25 per share. The stock finished the day's regular session with an 8.16% gain, closing at $6.36 per share. Concert, a biopharmaceutical company, has a market capitalization of $213.
